Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 19, 2015
Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world at Clinical Trial Supply Europe, February 25-26 in Cannes,...
read more
Today, attendees of the Prague-based International Society for Pharmaceutical Engineering (ISPE) Supply Chain Conference — sponsored by Cenduit LLC, a provider of services to the pharmaceutical, biopharmaceutical and medical device industries — will ...
read more
Thursday, December 05, 2019
CenExel Clinical Research has announced the acquisition of Research Centers of America (RCA) in Hollywood, FL.
read more
Cenix BioScience GmbH (Cenix), a leading preclinical contract research provider and technology developer specialized in RNAi- based genomics and high content screening-driven pharmacology, today announced that is has signed a research service ...
read more
Wednesday, March 07, 2018
Themis Bioscience and CEPI have announced a partnership under which Themis will provide advanced vaccine development and manufacturing for Lassa fever and MERS.
read more
Cerba Research, a leading global clinical trial laboratory services organization owned by Cerba HealthCare, announced today that they have joined forces with ACT Genomics under a joint venture model to create a purpose-built lab facility in Taiwan ...
read more
NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. Findings from this research are vital to NIAID’s efforts to advance vaccines, drugs, and ...
read more
Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through clinical development, and Veristat, LLC., a leading full service clinical research organization, today...
read more
Wednesday, December 12, 2012
The Almac Group’s Clinical Technologies business unit is pleased to announce that Charlie Morris has joined the company as Vice President of New Products and Services. In this role, Mr. Morris will report directly to Jim Murphy, President of Almac ...
read more
Chemomab Therapeutics,Ltd., a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, and AGC Biologics, a global Biopharmaceutical Contract Development ...
read more
Chi-Med and BeiGene have entered into a collaboration agreement to evaluate two of Chi-Med’s drug candidates, surufatinib and fruquintinib, with BeiGene’s anti-PD-1 antibody tislelizumab, for solid tumor cancers.
read more
Wednesday, March 20, 2013
The Society for Clinical Research Sites (SCRS) is pleased to announce that its President and Founder Christine Pierre has been nominated for the SmartCEO Brava! Award. This prestigious award is presented to women business leaders in the Baltimore ...
read more
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has been shortlisted for the 2023 Citeline Awards in the Best Use of Artificial Intelligence in ...
read more
Clearmind Medicine Inc. announced an agreement with IMP Clinical Supply Services.
IMP will be responsible for the global clinical supply chain of Clearmind’s proprietary drug candidate CMND-100 from manufacture to the various clinical sites.
read more
Tuesday, December 19, 2017
ClearPath has initiated a third research collaboration with Astellas Pharma to combat infections.
read more